star.
the latest figures mean that since january 2000, scottish widows has paid a total of £2.5bn in claims to more than 86,000 customers..
.richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..